Premium
P2‐055: Aβ OLIGOMER ELIMINATION IMPROVES COGNITIVE AND MOTORIC IMPAIRMENT IN DIFFERENT ALZHEIMER'S DISEASE MOUSE MODELS AFTER ORAL ADMINISTRATION
Author(s) -
Schemmert Sarah,
Schartmann Anna Elena,
Kutzsche Janine,
Willuweit Antje,
Willbold Dieter
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.740
Subject(s) - neurodegeneration , genetically modified mouse , dementia , disease , medicine , placebo , cognition , cognitive impairment , cognitive decline , alzheimer's disease , inflammation , transgene , neuroscience , pharmacology , psychology , pathology , psychiatry , chemistry , biochemistry , alternative medicine , gene
Nobuo Sanjo, Hiroya Kuwahara, Tetsuya Nagata, Yoichiro Nishida, Akiko Amano, Fumiko Furukawa, Kousei Hirata, Hiroyuki Maruoka, Makoto Nakakido, Tsumoto Kohei, Yasutaka Anraku, Kazunori Kataoka, Ichio Aoki, Etsuro Matsubara, Takami Tomiyama, Takanori Yokota, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan; Tokyo Medical and Dental University, Tokyo, Japan; The University of Tokyo, Tokyo, Japan; The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Innovation Center of NanoMedicine, Kawasaki, Japan; National Institutes for Quantum and Radiological Science and Technology, Chiba, Japan; Oita University Faculty of Medicine, Oita, Japan; Osaka City University, Osaka, Japan. Contact e-mail: n-sanjo. nuro@tmd.ac.jp